Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

Corus Pharma selected as a biotech company to watch

Corus Pharma announced yesterday that it has been selected as a member of FierceBiotech's annual "The Fierce 15." FierceBiotech Editor-in-Chief John D. Carroll observed "We applaud Corus' ongoing commitment to increasing the quality of life for people living with cystic fibrosis."

29 Jul 2004

Ohio State budget cuts jeopardize medical coverage

On July 1, the Ohio State Department of Health plans to implement a major budget cut for the Bureau for Children with Mental Handicaps (BCMH).

10 Jul 2004

£18m to upgrade genetic laboratories in England

Six areas in England are to receive a share of £18m to upgrade genetic laboratories and help patients get genetic test results quicker.

5 Jul 2004

Mucus may be the key to new treatments for cystic fibrosis

The surprising finding that people with cystic fibrosis (CF) produce too little airway mucus – rather than too much, as it commonly believed

1 Jul 2004

New £18M Medical Research Council facility

A new £18M Medical Research Council (MRC) facility to understand and compare the genetics of disease in mice and humans will be opened today, Wednesday 30 June, by Lord Sainsbury, Minister for Science and Technology.

29 Jun 2004

Gene chip technology can detect one of the commonest cystic fibrosis (CF) genetic mutations with 100% accuracy

A single genetic test that is capable of detecting all mutations involved in the development of cystic fibrosis could be just a few years away, the 20th annual conference of the European Society of Human Reproduction and Embryology heard today (Monday 28 June).

28 Jun 2004

Current legislation on preimplantation genetic diagnosis in Germany does not reflect the views of the general public

At present PGD is forbidden in Germany, but in one of the first large study of attitudes to PGD amongst the general population and infertile couples in Germany, the researchers found that the majority of Germans think the technique should be permitted.

28 Jun 2004

Cystic Fibrosis Foundation Therapeutics awards $21 million to Vertex

Vertex Pharmaceuticals Incorporated has announced that it has expanded its drug discovery and development collaboration with Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation.

24 May 2004

Scientists move closer toward treatment for degenerative diseases

Scientists at McGill University's Faculty of Medicine have discovered a key step that will provide new targets for treatments of many degenerative diseases such as Alzheimer's, Cystic Fibrosis and Diabetes.

17 May 2004

FDA today alerted consumers not to purchase or use a recalled lot of DU brand nasal decongestant spray

FDA today alerted consumers not to purchase or use a recalled lot of DU brand nasal decongestant spray (distributed by Drugs Unlimited, of Puerto Rico) because it may be contaminated with Burkholderia cepacia – a bacterium that could cause serious, potentially life-threatening infections in some patients. Individuals with compromised immune systems, especially those with cystic fibrosis, could be at risk.

17 May 2004

AAP expands recommendations for annual influenza immunizations to include children ages 6 through 23 months

The American Academy of Pediatrics (AAP) has expanded its recommendations for annual influenza immunizations to include children ages 6 through 23 months, as well as close contacts and caregivers of children under age 2.

3 May 2004

FDA requires pancreatic extract manufacturers to get approval to remain on the market

The Food and Drug Administration (FDA) today formally notified manufacturers of pancreatic insufficiency products that these drugs must get approval by FDA within the next four years in order to remain on the market.

28 Apr 2004

FDA mandates approval for all pancreatic enzyme replacements

The Cystic Fibrosis Foundation has announced its support of the Food and Drug Administration's (FDA) requirement that manufacturers of pancreatic enzyme replacements obtain FDA approval for their products within the next four years.

27 Apr 2004

Inspire announces positive results in cystic fibrosis study

Inspire Pharmaceuticals, Inc. today announced top-line results in a Phase II study of INS37217 Respiratory in patients with mild cystic fibrosis (CF) lung disease.

27 Apr 2004

Learn to control your child's asthma with new book from The Children's Hospital of Philadelphia

While asthma can’t be cured, it can be treated and controlled so that your child can enjoy a healthier, more active life. In this important guide, Children's Hospital experts clearly explain what asthma is and how parents, caregivers and young patients can manage it successfully.

26 Apr 2004

Spice turmeric corrects the cystic fibrosis defect

Scientists at The Hospital for Sick Children (Sick Kids) and Yale University School of Medicine have found that a compound in the spice turmeric corrects the cystic fibrosis defect in mice. This research is reported in the April 23, 2004 issue of the journal Science.

24 Apr 2004

Clinical trial of curcumin in people with cystic fibrosis

Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, today announced that it is funding a clinical trial of curcumin in people with cystic fibrosis (CF).

22 Apr 2004

Turmeric corrects the cystic fibrosis defect

22 Apr 2004

Desensitization Useful for Allergy to Life-Saving Drug

When patients with life-threatening bacterial infections are allergic to antibiotics, drug desensitization may be an option when no other alternative exists according to a report published this month in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).

21 Apr 2004

Can public health promotion beat disease?

Huge efforts are under way to address health problems such as SARS, HIV, diabetes and many other illnesses by developing vaccines or therapeutic drugs.

20 Apr 2004